Purdue Pharma and its owners, the Sackler family, have proposed a settlement in the nationwide opioids lawsuit that would be worth $10 billion–$12 billion, NBC News reports.
Why it matters: Purdue is the focal point of this litigation, but the proposed settlement would amount to only a fraction of what the opioid epidemic has cost the U.S. — and only about a third of Purdue's OxyContin sales.
The big picture: The total settlement would include donations of life-saving anti-overdose drugs and the proceeds from the sale of other drugs. The Sacklers would also sell off a separate business to contribute another $3 billion. The family is worth an estimated $13 billion, and Purdue made more than $35 billion from OxyContin sales, per NBC.
Go deeper: Why the first opioids lawsuit verdict is both big and small
